Your browser version may not work well with NCBI's Web applications. More information here...
1: Breast Cancer Res. 2000;2(3):191-6. Epub 2000 Mar 25.
Related Articles, Links
Click here to read Click here to read
Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors.

Dickson C, Spencer-Dene B, Dillon C, Fantl V.

Imperial Cancer Research Fund, London, UK. dickson@icrf.icnet.uk

The fibroblast growth factors [Fgfs (murine), FGFs (human)] constitute a large family of ligands that signal through a class of cell-surface tyrosine kinase receptors. Fgf signalling has been associated in vitro with cellular differentiation as well as mitogenic and motogenic responses. In vivo, Fgfs are critical for animal development, and some have potent angiogenic properties. Several Fgfs have been identified as oncogenes in murine mammary cancer, where their deregulation is associated with proviral insertions of the mouse mammary tumour virus (MMTV). Thus, in some mammary tumours of MMTV-infected mouse strains, integration of viral genomic DNA into the somatic DNA of mammary epithelial cells was found to have caused the inappropriate expression of members of this family of growth factors. Although examination of human breast cancers has shown an altered expression of FGFs or of their receptors in some tumours, their role in the causation of breast disease is unclear and remains controversial.

Publication Types:
PMID: 11250709 [PubMed - indexed for MEDLINE]

PMCID: PMC138774